Concepedia

Shijia Zhang

SZ

Statistics

Publications

3

Citations

128

H-Index

3

Active since

2018

Affiliations

Dana-Farber Cancer Institute(Current)

Brigham and Women's Hospital

Stevens Institute of Technology

Massachusetts General Hospital

Harvard University

Shijia Zhang is an author at Dana-Farber Cancer Institute specializing in oncology, medicine, and non-small cell lung cancer therapy.

ORCID

Publications per year

2018–2023

3

Publications

3

A Phase II Clinical Trial of Apatinib in Pretreated Advanced Non-squamous Non–small-cell Lung Cancer

Fengying Wu, Shijia Zhang, Anwen Xiong et al. · Clinical Lung Cancer · 2018 · 62 citations

, , +8

Prediction of early-stage melanoma recurrence using clinical and histopathologic features

Guihong Wan, Nga Nguyen, Feng Liu et al. · npj Precision Oncology · 2022 · 49 citations · Full text

, , +17

Influence of melanoma type on incidence and downstream implications of cutaneous immune-related adverse events in the setting of immune checkpoint inhibitor therapy

Nga Nguyen, Guihong Wan, Pearl Ugwu‐Dike et al. · Journal of the American Academy of Dermatology · 2023 · 17 citations · Full text

, , +17

1–3 of 3